Variation in Biosimilar Uptake in Europe

JAMA Intern Med. 2021 Mar 1;181(3):403-404. doi: 10.1001/jamainternmed.2020.6567.
No abstract available

Publication types

  • Comment

MeSH terms

  • Biosimilar Pharmaceuticals*
  • Drug Approval
  • Europe
  • Humans

Substances

  • Biosimilar Pharmaceuticals